Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
A new study found that switching from a primary national plan of egg-based vaccines to cell-based vaccines for the flu would significantly reduce the impact of the seasonal virus at a lesser production and distribution cost.
Crystal Hodge discusses being transparent about adverse effects of the MMR vaccine and educating patients about measles.
Specialty pharmacies help support their continuity of care with practiced disaster response plans.
Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.
The pilot Will Evaluate Measure Concepts and Data Exchange in Value-Based Arrangements.
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.
According to poison control data, many children aged 0 to 17 experience toxicity from over-the-counter analgesics like ibuprofen and acetaminophen.
Micah Cost, PharmD, MS, CAE, discusses the biggest issues currently impacting the pharmacy profession.
Study results show improvement in progression-free survival at 22 months.
The remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.
Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
According to data science expert Don Roosan, PharmD, PhD, the capabilities of ChatGPT are just the beginning of what the future of artificial intelligence may look like in pharmacy practice.
IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.